Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ASH Research Collaborative
With
ModernaTX, Inc.
The purpose of this project is to implement and establish the feasibility of a decentralized real-world evidence study network for patients with multiple myeloma and to monitor outcomes related to COVID-19 infection in this immunosuppressed population. Subjects with multiple myeloma will be invited to participate. The electronic portal will handle all consenting activities. Participants will be asked to complete specific study procedures electronically, including permission for electronic health record (EHR) data transfer. Participants will be asked to complete electronic questionnaires periodically.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of multiple myeloma per the International Myeloma Working Group and currently receiving active treatment for any phase of the disease, including initial therapy, maintenance, or relapsed disease.
Access to the internet
An active patient portal (or willingness to activate)
Willing to electronically sign the study-specific informed consent and authorization form
You may not be if
Non-English speaking
Lack of internet access
Cognitive impairment precluding ability to provide informed consent
Clareo Health | COVID19 OutcomeS in Myeloma and the Impact of VaCcines
